Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) for Patients With Failed Surgical Aortic Bioprosthesis.

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 111 participants.

Also called NCT07524595

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 111 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07524595
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Ireland (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07524595. Randomized; no masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2027-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) for Patients With Failed Surgical Aortic Bioprosthesis.
Acronym
REVIVAL
Condition
AORTIC VALVE DISEASES
Condition
Valve-in-valve Procedures
Condition
Surgical Valve Replacement
Condition
Valve Disease, Aortic
Intervention (Device)
Hydra THV Series
Intervention (Device)
Sapien THV Series and MyVal THV Series
Lead sponsor
National University of Ireland, Galway, Ireland (class: other)

Record details

Record id
cardio:ct-nct07524595
Content hash
51aae7cf43d7505b3b84c206b96648379577490fc5ea8fa87f8788ff46285f36